I did a comparision of the two trials in a different thread which ill copy below:
Lets do a comparison of Ruxolitnib vs Remestemcel-L trials:
Trial:Day 28 ORR:
- Single arm open label 49 patients
- Single arm open label 54 patients (Study 001)
Day 180 Survival:
- 40.7%-44.4% on grade 3-4 (grade c-d)
- 61%-67% on grade 3-4 (grade c-d)
Safety:
- 51% (n=25)
- 69% (n=37)
FDA Decision
- Multiple safety concerns/side effects including infections, sepsis, uti's, thrombosis and animia (adverse events lead to 31% of patients discontinuing treatment)
- No safety concerns identified with a safety profile similar to placebo (adverse events lead to 15% of patients discontinuing treatment)
- Approved
- ODAC voted 9-1 in favour of efficacy however FDA issued a CRL recommending a further trial to establish efficacy and to provide more scientific rationale to demonstrate potency relationships
Ruxolitnib has had a previous trial for the treatment of myelofibrosis. The trial results clearly show that from the available data, Remestemcel-L is a superior treatment with a much better safety profile.
Could msb argue that if the COVID-19 trial is successful this would provide sufficient evidence of relevant efficacy and safety similar to Ruxolitnib extension from myelofibrosis to GvHD based on the 1 single arm trial above?
- Forums
- ASX - By Stock
- MSB
- Ruxolitinib vs Ryoncil
MSB
mesoblast limited
Add to My Watchlist
1.30%
!
$2.28

Ruxolitinib vs Ryoncil, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.28 |
Change
-0.030(1.30%) |
Mkt cap ! $2.918B |
Open | High | Low | Value | Volume |
$2.32 | $2.39 | $2.24 | $13.10M | 5.680M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 44474 | $2.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 30176 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 44030 | 2.270 |
4 | 31511 | 2.260 |
4 | 12725 | 2.250 |
5 | 28464 | 2.240 |
4 | 30100 | 2.230 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 30176 | 3 |
2.300 | 15322 | 3 |
2.310 | 12000 | 2 |
2.320 | 21980 | 6 |
2.330 | 10410 | 2 |
Last trade - 16.17pm 22/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |